BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
5/19/22 Zealand Pharma (ZEAL) Zegalogue for Hyperinsulinemia/Hypoglycemia Subscribers Only Subscribers Only Subscribers Only
5/18/22 Enanta Pharmaceuticals (ENTA) EDP-938 for Respiratory Syncytial Virus (RSV) Treatment Subscribers Only Subscribers Only Subscribers Only
5/16/22 Bristol Myers Squibb (BMY) Opdivo for Bladder Cancer Subscribers Only Subscribers Only Subscribers Only
5/13/22 UCB (UCB) Bimzelx for Psoriasis Subscribers Only Subscribers Only Subscribers Only
5/12/22 Bristol Myers Squibb (BMY) Deucravacitinib for Psoriasis Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
03/19/22 Subscribers Only Subscribers Only Regulatory - PDUFA for sNDA/sBLA
03/31/22 Subscribers Only Subscribers Only Trial Data - Top-Line Results
05/12/22 Subscribers Only Subscribers Only Trial Data - Other
05/12/22 Subscribers Only Subscribers Only Trial Data - Other
05/12/22 Subscribers Only Subscribers Only Trial Data - Top-Line Results
Back to the top Back to the top